Item 8.01 Other Events
On November 5, 2020, Viela Bio, Inc. (the "Company") issued a press release
entitled "Viela Bio Announces Final Results from Phase 1b Trial of VIB7734 in
Patients with Cutaneous Lupus Erythematosus", which is attached hereto as
Exhibit 99.1 and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Press release dated November 5, 2020
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses